Patents by Inventor Edward M. Kaye

Edward M. Kaye has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • METHODS FOR TREATING MUSCULAR DYSTROPHY WITH CASIMERSEN
    Publication number: 20220152086
    Abstract: The present disclosure provides, among other things, improved compositions and methods for treating muscular dystrophy. For example, the disclosure provides methods for treating Duchenne muscular dystrophy patients having a mutation in the DMD gene that is amenable to exon 45 skipping by administering an effective amount of casimersen.
    Type: Application
    Filed: March 25, 2020
    Publication date: May 19, 2022
    Inventor: Edward M. Kaye
  • Compositions for treating muscular dystrophy
    Patent number: 10364431
    Abstract: Improved compositions and methods for treating muscular dystrophy by administering antisense molecules capable of binding to a selected target site in the human dystrophin gene to induce exon skipping are described.
    Type: Grant
    Filed: May 24, 2017
    Date of Patent: July 30, 2019
    Assignee: Sarepta Therapeutics, Inc.
    Inventor: Edward M. Kaye
  • Compositions for treating muscular dystrophy
    Patent number: 10337003
    Abstract: Improved compositions and methods for treating muscular dystrophy by administering antisense molecules capable of binding to a selected target site in the human dystrophin gene to induce exon skipping are described.
    Type: Grant
    Filed: November 22, 2016
    Date of Patent: July 2, 2019
    Assignee: Sarepta Therapeutics, Inc.
    Inventor: Edward M. Kaye
  • Compositions for treating muscular dystrophy
    Patent number: 9506058
    Abstract: Improved compositions and methods for treating muscular dystrophy by administering antisense molecules capable of binding to a selected target site in the human dystrophin gene to induce exon skipping are described.
    Type: Grant
    Filed: March 14, 2014
    Date of Patent: November 29, 2016
    Assignee: Sarepta Therapeutics, Inc.
    Inventor: Edward M. Kaye
  • COMPOSITIONS FOR TREATING MUSCULAR DYSTROPHY
    Publication number: 20140315862
    Abstract: Improved compositions and methods for treating muscular dystrophy by administering antisense molecules capable of binding to a selected target site in the human dystrophin gene to induce exon skipping are described.
    Type: Application
    Filed: March 14, 2014
    Publication date: October 23, 2014
    Applicant: Sarepta Therapeutics, Inc.
    Inventor: Edward M. Kaye